Select a Size
1.050,00 kr.
Inquire
About This Item
Skip To
Agency
ChP
JPE
Ph. Eur.
USP
Quality Level
product line
EMPROVE® ESSENTIAL
form
fine powder
particle size
180-260 μm (d50)
mp
160-240 °C
application(s)
pharmaceutical
solid formulation
shipped in
ambient
storage temp.
15-25°C
InChI
1S/C2H4O/c1-2-3/h2-3H,1H2
InChI key
IMROMDMJAWUWLK-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
1 of 4
This Item | 1.41439 | 1.41353 | 1.41350 |
|---|---|---|---|
| application(s) pharmaceutical | application(s) controlled release | application(s) controlled release | application(s) controlled release |
| agency ChP, Ph. Eur., JPE, USP | agency ChP, JPE, Ph. Eur., USP | agency ChP, JPE, Ph. Eur., USP | agency ChP, JPE, Ph. Eur., USP |
| form fine powder | form fine powder | form scales | form scales |
| product line EMPROVE® ESSENTIAL | product line EMPROVE® ESSENTIAL | product line EMPROVE® ESSENTIAL | product line EMPROVE® ESSENTIAL |
| particle size 180-260 μm (d50) | particle size 60-100 μm (d50) | particle size - | particle size - |
| mp 160-240 °C | mp 160-240 °C | mp 160-240 °C | mp 160-240 °C |
General description
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Application
Features and Benefits
- Excellent surface finishing - improve the appearance of your formulation
- Rapid preparation of coating liquids even at room temperature
- Low viscosity of coating liquids at high polymer concentration – enables reduced process times and enhanced efficiency
- Stable moisture and oxygen barrier - effective protection of moisture-sensitive APIs
Legal Information
Storage Class Code
11 - Combustible Solids
WGK
WGK 1
Regulatory Listings
Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.
EU REACH Annex XVII (Restriction List)
Stay compliant with GMP using the Emprove® Program
Accelerate qualification, maintain compliance, and save time with Emprove® Dossiers.
Note: you will be brought to EmproveSuite.com. Your username and password are separate from SigmaAldrich.com and may differ.
Register for free and access Emprove® Dossiers within minutes. Upgrade your subscription plan to unlock advanced and customized content in the Emprove® Suite
Not finding what you are looking for? Visit the Emprove® Program Help page.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.
Related Content
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service